About Ovid Therapeutics
Conquering brain disorders with courageous science
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- New York, New York
- Founded
- 2014
- Company type
- Public Company
Ovid Therapeutics is a biopharmaceutical company striving to calm the storm that causes seizures by developing new medicines for epilepsies and brain conditions. For those who need relief, we must succeed - their hopes are our aspirations. We act with urgency, ingenuity and integrity as we seek a future free of seizures.
At Ovid, we are pursuing small molecule compounds with untapped potential. Applying our nimble, proven approach to accelerate clinical development, we aim to translate our molecules into first-in-class or best-in-class medicines. The patient, clinician and academic communities are our collaborators in every step of development from bench to bedside.
Our accomplished team holds a track record of success in making medicines for rare diseases and neurology. Our goal is bold for the communities we serve.
For more information, please visit www.ovidrx.com.
Review our community guidelines: http://www.ovidrx.com/community-guidelines/
Company locations
441 9th Avenue, New York, New York 10001, US
75 Kneeland St, 14th floor, Boston, MA 02111, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 20,666
- People linked to this company
- 42
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.